z-logo
open-access-imgOpen Access
Neuroprotective Effects of Adenosine Monophosphate- Activated Protein Kinase Inhibition and Gene Deletion in Stroke
Author(s) -
Jun Li,
Zhiyuan Zeng,
Benoı̂t Viollet,
Gabriele V. Ronnett,
Louise D. McCullough
Publication year - 2007
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.107.490904
Subject(s) - ampk , neuroprotection , protein kinase a , medicine , amp activated protein kinase , adenosine , adenosine monophosphate , stroke (engine) , endocrinology , pharmacology , phosphorylation , microbiology and biotechnology , biology , mechanical engineering , engineering
5' adenosine monophosphate-dependent protein kinase (AMPK) acts as a metabolic sensor. AMPK is elevated under ischemic conditions, but the role of AMPK in ischemic brain remains controversial. In this study, we examined the effects of AMPK inhibition using both pharmacological and genetic approaches in an in vivo stroke model.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom